Nucleic Acid Amplification Test For Trichomoniasis

Fda approval of the first nucleic acid amplification test for trichomoniasis 5 years ago has paved the way for more accurate and reliable testing compared with wet mount tests culture or rapid point of care tests.

Nucleic acid amplification test for trichomoniasis. Women diagnosed with t. Trichomonas is not fda approved for males on the naat testing platform at this time. Vaginalis naat testing among clinic providers during the first year of test availability in addition to t. Background trichomonas vaginalis is the most common nonviral sexually transmitted infection.

Test code mtrna trichomonas vaginalis nucleic acid amplification male patients varies performing laboratory mayo clinic laboratories in rochester reporting name t vaginalis misc amplified rna specimen type varies necessary information. Specimen source is required. The objective of this study was to determine the uptake of t. Offer the highest sensitivity and specificity for detection of trichomoniasis.

4 11 automation provides. The aptima test utilizes target capture transcription mediated amplification tma and hybridization protection assay hpa technologies for detection of t vaginalis ribosomal rna rrna. Trichomonas vaginalis nucleic acid amplification female patients varies. Vaginalis nucleic acid amplification testing naat recently became available at the university of alabama at birmingham human immunodeficiency virus hiv clinic.

Vaginalis naat testing among clinic providers during the first year of. Cautions the effects of tampon use douching and specimen collection variables have not been assessed for their impact on the detection of trichomonas vaginalis. Vaginalis nucleic acid amplification testing naat recently became available at the university of alabama at birmingham human immunodeficiency virus hiv clinic. The purpose of this study was to examine how long t.

The objective of this study was to determine the uptake of t. The aptima test utilizes target capture transcription mediated amplification tma and hybridization protection assay. Vaginalis nucleic acid is detectable postmetronidazole mtz treatment. 10 this test the aptima trichomonas vaginalis assay by hologic marlborough mass offers 95 to 100 sensitivity and 95 to 100 specificity figure 2.

We will run the test is requested on a male however we will report it with a disclaimer indicating that the result are not fda approved for male sources and shoud be interpreted with caution. Vaginalis prevalence and predictors based on naat results. Trichomonas vaginalis testing by aptima is approved for endocervical vaginal and female urine specimens only.